AVORO CAPITAL ADVISORS LLC 13D/13G Filings for Cue Biopharma, Inc. (CUE)

AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Cue Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-12
08:13 am
Sale		2020-12-3113GCue Biopharma, Inc.
CUE		AVORO CAPITAL ADVISORS LLC452,500
1.500%		-1,417,500decrease
(-75.80%)		Filing
2020-02-14
10:24 am
Purchase		2019-12-3113GCue Biopharma, Inc.
CUE		AVORO CAPITAL ADVISORS LLC1,870,000
8.100%		1,870,000increase
(New Position)		Filing